Thermal Gradient is a developer of devices and systems for rapid, easy-to-use molecular diagnostics. The company’s proprietary rapid thermal cycling and nucleic acid sample preparation technologies enable extremely fast and easy to use systems. Battery power and low complexity sample to answer operation allow TG's technology to be brought to point-of-care whether for field use in low resource settings or distributed diagnostics in the developed world. The same advantages open up significant licensing and cartridge supply opportunities in bio-defense and other molecular biological applications.
Thermal Gradient was founded with the intention to bring its core technology of very rapid PCR and sample preparation to a suite of products that both better address existing markets and enables new markets that cannot be addressed with existing technologies. Thermal Gradient is more that a technology company, though. Thermal Gradient's business focus has always been to seek opportunties where our unique and proprietary technology is best suited for new products that address markets with unmet needs under a sound financial model.
Thermal Gradient was founded by individuals with long and successful track records for developing high technology products in in vitro diagnostics. Our culture is one of strong and spirited collaboration, internally as well as with the company's long term valued partners. We welcome the opportunity to discuss additional opportunities with partners and collaborators that bring additional technologies, resources, and market potentials with Thermal Gradient's reach.
THERMAL GRADIENT'S MISSION & PHILOSOPHY
THE WORLDS FASTEST MOLECULAR DIAGNOSTIC
Infectious disease detection and management
Rapid field detection of bio-threats & forward personnel health monitoring
FOOD & WATER
Food & water purity testing, treatment centers or point of collection
Rapid, simple, on-site bio-metric profiling
RESEARCH / RUO
Products for research and laboratory use
Livestock and animal care, management, and contamination prevention
The FlashAMP instrument and cartridge system in geared to the non-diagnostic market. It will provide researchers with the ability to perform quantitative PCR from prepared nucleic acid samples.
FlashDirect is a complete sample-to-answer system that provides diagnostic results from raw specimens. Developed with MRSA as the primary test, the system is capable of virtually any nucleic acid based target. The FlashDirect platform is also adaptable for bioDefense and forensic applications.